NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,195,578 | +59.7% | 247,469 | +58.2% | 0.04% | +32.1% |
Q2 2023 | $15,780,887 | +23.3% | 156,433 | +12.6% | 0.03% | +16.7% |
Q1 2023 | $12,797,527 | +3.9% | 138,956 | +2.3% | 0.02% | -4.0% |
Q4 2022 | $12,319,423 | +16.4% | 135,789 | -2.5% | 0.02% | +4.2% |
Q3 2022 | $10,583,000 | -9.8% | 139,219 | +0.3% | 0.02% | -7.7% |
Q2 2022 | $11,735,000 | -1.6% | 138,743 | +6.6% | 0.03% | +13.0% |
Q1 2022 | $11,926,000 | +9.2% | 130,133 | +4.3% | 0.02% | +9.5% |
Q4 2021 | $10,918,000 | +12.9% | 124,792 | +5.5% | 0.02% | +5.0% |
Q3 2021 | $9,674,000 | -13.3% | 118,256 | -3.3% | 0.02% | -16.7% |
Q2 2021 | $11,159,000 | +8.7% | 122,273 | +1.9% | 0.02% | -4.0% |
Q1 2021 | $10,269,000 | -17.3% | 120,045 | -8.7% | 0.02% | -24.2% |
Q4 2020 | $12,412,000 | +10.1% | 131,446 | +1.4% | 0.03% | -2.9% |
Q3 2020 | $11,275,000 | -2.1% | 129,624 | -1.6% | 0.03% | -12.8% |
Q2 2020 | $11,515,000 | -1.7% | 131,740 | -42.5% | 0.04% | -18.8% |
Q1 2020 | $11,712,000 | – | 229,306 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
Elefante Mark B | 4,579 | $333,000 | 4.02% |
COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |